Board of directors

Born 1961. Board member since 2024.

Independent in relation to the company as well as to its major shareholders. Stig holds a Master’s Degree in Business Administration and Management from Aalborg University. Stig is a professional board member and investor. He has 25 years of management experience, mainly from H. Lundbeck A/S where he held a number of positions in Denmark and abroad.

Shareholding: 384 000.

Close

Born 1971. Board member since 2026.

Close

Born 1944. Board member since 2016.

Sven-Christer holds a Bachelor of Science (B.Sc) from Lund University and has studied the Advanced General Management Program, INSEAD / CEDEP. Sven-Christer is a member of the Board of Directors of CEVA, Inc. (NASD: CEVA) since 2003. CEVA operates in the markets for signal processors, sensor networks and AI processors. He was CEO at Ericsson between 1998-99. Recent Board assignments include Assa Abloy AB (2001-2015), SprinNextel, Inc. (NYSE: S, 2008-2013) and the Swedish Defense Materiel Administration (Chairman 2010-2017).

Shareholding: 80 270 shares through Ripasso AB

Independent in relation to the company as well as to its major shareholders.

Close

Born 1945. Board member since 2016.

Mats holds a Master of Business Administration and is a former authorized public accountant. After a career as a public accountant, his pharmaceutical career began in what later became the Pharmacia group in the mid-seventies. Mats has more than forty years of experience in the pharmaceutical industry and has been part of several management groups within Pharmacia and is responsible for several transformative M&As. Among other things, as a driving force and responsible for the spin-off and stock exchange introduction of Biovitrum (today SOBI), where he was also its first CEO. Later Board assignments include Lundbeck AS, (2003-2013, Chariman 2011-2013), Genmab AS (Chairman), Ablynx NV, 2007-2013 (sold to Sanofi), Moberg Pharma AB (Chairman 2010-2016).

Shareholding: 443 500 shares

Independent in relation to the company as well as to its major shareholders.

Close